Published in Biomaterials on May 01, 2008
Factors affecting the longevity and strength in an in vitro model of the bone-ligament interface. Ann Biomed Eng (2010) 0.89
Sustained and localized in vitro release of BMP-2/7, RANKL, and tetracycline from FlexBone, an elastomeric osteoconductive bone substitute. J Orthop Res (2009) 0.87
Self-setting calcium orthophosphate formulations. J Funct Biomater (2013) 0.81
Biodegradable Materials for Bone Repair and Tissue Engineering Applications. Materials (Basel) (2015) 0.79
pHEMA-nHA encapsulation and delivery of vancomycin and rhBMP-2 enhances its role as a bone graft substitute. Clin Orthop Relat Res (2013) 0.77
Morphology, composition, and bioactivity of strontium-doped brushite coatings deposited on titanium implants via electrochemical deposition. Int J Mol Sci (2014) 0.77
Strontium coating by electrochemical deposition improves implant osseointegration in osteopenic models. Exp Ther Med (2014) 0.77
Regulation of cancer cell migration and bone metastasis by RANKL. Nature (2006) 5.27
How smart do biomaterials need to be? A translational science and clinical point of view. Adv Drug Deliv Rev (2012) 1.38
Osteoconduction and osteoinduction of low-temperature 3D printed bioceramic implants. Biomaterials (2007) 1.26
Antimicrobial titanium/silver PVD coatings on titanium. Biomed Eng Online (2006) 1.23
Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair. Biomaterials (2007) 1.16
Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway. Bone (2007) 1.09
Silver-doped calcium phosphate cements with antimicrobial activity. Acta Biomater (2011) 1.06
Ionic modification of calcium phosphate cement viscosity. Part I: hypodermic injection and strength improvement of apatite cement. Biomaterials (2004) 1.04
3D powder printed calcium phosphate implants for reconstruction of cranial and maxillofacial defects. J Craniomaxillofac Surg (2010) 1.01
Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses. J Bone Miner Res (2003) 1.00
In vivo degradation of low temperature calcium and magnesium phosphate ceramics in a heterotopic model. Acta Biomater (2011) 0.99
CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone. Am J Pathol (2011) 0.99
Direct 3D powder printing of biphasic calcium phosphate scaffolds for substitution of complex bone defects. Biofabrication (2014) 0.99
Matrigel improves functional properties of human submandibular salivary gland cell line. Int J Biochem Cell Biol (2011) 0.99
Angiogenesis in calcium phosphate scaffolds by inorganic copper ion release. Tissue Eng Part A (2009) 0.98
Biologically mediated resorption of brushite cement in vitro. Biomaterials (2005) 0.98
Peptide-functionalized gold nanorods increase liver injury in hepatitis. ACS Nano (2012) 0.98
Craniofacial vertical bone augmentation: a comparison between 3D printed monolithic monetite blocks and autologous onlay grafts in the rabbit. Biomaterials (2009) 0.96
Mathematical modeling of spatio-temporal dynamics of a single bone multicellular unit. J Bone Miner Res (2009) 0.95
Photoactivation of CdSe/ZnS quantum dots embedded in silica colloids. Small (2008) 0.95
Influence of calcium phosphate crystal assemblies on the proliferation and osteogenic gene expression of rat bone marrow stromal cells. Biomaterials (2006) 0.94
Biocompatibility of magnesium phosphate minerals and their stability under physiological conditions. Acta Biomater (2011) 0.93
Mathematical modeling in bone biology: from intracellular signaling to tissue mechanics. Bone (2010) 0.92
Breast cancer-derived factors stimulate osteoclastogenesis through the Ca2+/protein kinase C and transforming growth factor-beta/MAPK signaling pathways. J Biol Chem (2009) 0.92
The effect of amorphous pyrophosphate on calcium phosphate cement resorption and bone generation. Biomaterials (2013) 0.92
In vitro biodegradation of three brushite calcium phosphate cements by a macrophage cell-line. Biomaterials (2006) 0.91
Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials (2006) 0.91
Accelerated mineralization of dense collagen-nano bioactive glass hybrid gels increases scaffold stiffness and regulates osteoblastic function. Biomaterials (2011) 0.90
Magnesium-sputtered titanium for the formation of bioactive coatings. Acta Biomater (2009) 0.90
The importance of particle size and DNA condensation salt for calcium phosphate nanoparticle transfection. Biomaterials (2008) 0.89
Rapamycin inhibits osteolysis and improves survival in a model of experimental bone metastases. Cancer Lett (2011) 0.89
Ascorbic acid accelerates osteoclast formation and death. Bone (2009) 0.89
Passive and active in vitro resorption of calcium and magnesium phosphate cements by osteoclastic cells. Tissue Eng Part A (2010) 0.89
Complex dynamics of osteoclast formation and death in long-term cultures. PLoS One (2008) 0.88
Recent progress in interfacial tissue engineering approaches for osteochondral defects. Ann Biomed Eng (2012) 0.88
Minimally invasive maxillofacial vertical bone augmentation using brushite based cements. Biomaterials (2008) 0.88
Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis. Bone (2010) 0.87
Conventional and tissue-specific inactivation of the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). J Cell Biochem (2003) 0.87
Egr-1 negatively regulates calsequestrin expression and calcium dynamics in ventricular cells. Cardiovasc Res (2008) 0.87
Low temperature fabrication of magnesium phosphate cement scaffolds by 3D powder printing. J Mater Sci Mater Med (2010) 0.87
Brushite-collagen composites for bone regeneration. Acta Biomater (2008) 0.87
Influence of powder/liquid mixing ratio on the performance of a restorative glass-ionomer dental cement. Biomaterials (2003) 0.87
Magnetic resonance imaging of tumors colonized with bacterial ferritin-expressing Escherichia coli. PLoS One (2011) 0.87
Osteoprotegerin in bone metastases: mathematical solution to the puzzle. PLoS Comput Biol (2012) 0.86
ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone. Breast Cancer Res (2012) 0.86
Strontium modified biocements with zero order release kinetics. Biomaterials (2008) 0.85
Non-Ototoxic Local Delivery of Bisphosphonate to the Mammalian Cochlea. Otol Neurotol (2015) 0.85
Modeling vancomycin release kinetics from microporous calcium phosphate ceramics comparing static and dynamic immersion conditions. Acta Biomater (2008) 0.85
Osteoclast precursors acquire sensitivity to breast cancer derived factors early in differentiation. Bone (2008) 0.84
Preparation of tricalcium phosphate/calcium pyrophosphate structures via rapid prototyping. J Mater Sci Mater Med (2008) 0.84
Collagen biomineralization in vivo by sustained release of inorganic phosphate ions. Adv Mater (2010) 0.84
Comparing the efficacy of three bioceramic matrices for the release of vancomycin hydrochloride. J Biomed Mater Res B Appl Biomater (2010) 0.84
Characterization of chlorhexidine-releasing, fast-setting, brushite bone cements. Acta Biomater (2008) 0.83
Surface engineering of stainless steel materials by covalent collagen immobilization to improve implant biocompatibility. Biomaterials (2005) 0.83
Injectability and mechanical properties of magnesium phosphate cements. J Mater Sci Mater Med (2011) 0.83
Silk fibroin derived polypeptide-induced biomineralization of collagen. Biomaterials (2011) 0.83
An airway smooth muscle cell niche under physiological pulsatile flow culture using a tubular dense collagen construct. Biomaterials (2012) 0.83
Factors influencing calcium phosphate cement shelf-life. Biomaterials (2005) 0.83
Influence of spacer length on heparin coupling efficiency and fibrinogen adsorption of modified titanium surfaces. Biomed Eng Online (2007) 0.83
Alendronate affects calcium dynamics in cardiomyocytes in vitro. Vascul Pharmacol (2009) 0.83
Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. J Control Release (2007) 0.82
In vitro transfer of keratinocytes: comparison of transfer from fibrin membrane and delivery by aerosol spray. J Biomed Mater Res B Appl Biomater (2005) 0.82
Phase composition, mechanical performance and in vitro biocompatibility of hydraulic setting calcium magnesium phosphate cement. Acta Biomater (2009) 0.82
Titanium-tethered vancomycin prevents resistance to rifampicin in Staphylococcus aureus in vitro. PLoS One (2012) 0.82
Chemical characterization of a degradable polymeric bone adhesive containing hydrolysable fillers and interpretation of anomalous mechanical properties. Acta Biomater (2009) 0.82
Antimicrobial potency of alkali ion substituted calcium phosphate cements. Biomaterials (2005) 0.82
Fabrication of computationally designed scaffolds by low temperature 3D printing. Biofabrication (2013) 0.81
Hard implant coatings with antimicrobial properties. J Mater Sci Mater Med (2011) 0.81
Breast cancer at bone metastatic sites: recent discoveries and treatment targets. J Cell Commun Signal (2011) 0.81
Effects of nanoparticle surface-coupled peptides, functional endgroups, and charge on intracellular distribution and functionality of human primary reticuloendothelial cells. Nanomedicine (2012) 0.81
Mesenchymal stem cell-seeded multilayered dense collagen-silk fibroin hybrid for tissue engineering applications. Biotechnol J (2011) 0.81
Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin. Breast Cancer Res Treat (2013) 0.81
Fibrillin-1 directly regulates osteoclast formation and function by a dual mechanism. J Cell Sci (2013) 0.81
The effect of Cu(II)-loaded brushite scaffolds on growth and activity of osteoblastic cells. J Biomed Mater Res A (2012) 0.80
Three-dimensional mineralization of dense nanofibrillar collagen-bioglass hybrid scaffolds. Biomacromolecules (2010) 0.80
Physicochemical and cell biological characterization of PMMA bone cements modified with additives to increase bioactivity. J Biomed Mater Res B Appl Biomater (2012) 0.80
Intracellular and extracellular T1 and T2 relaxivities of magneto-optical nanoparticles at experimental high fields. Magn Reson Med (2010) 0.80
Combining particle size distribution and isothermal calorimetry data to determine the reaction kinetics of alpha-tricalcium phosphate-water mixtures. Acta Biomater (2006) 0.80
Mechanical properties and drug release behavior of bioactivated PMMA cements. J Biomater Appl (2010) 0.79
Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase. J Biol Chem (2010) 0.79
Reproducible quantification of osteoclastic activity: characterization of a biomimetic calcium phosphate assay. J Biomed Mater Res B Appl Biomater (2013) 0.79
Frozen delivery of brushite calcium phosphate cements. Acta Biomater (2008) 0.79